GlassScriptPhysician profile
Rosetta B Stanford
NPI 1972575629
$1,262.08
in general payments reported to CMS, 2019-2025
17 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $270 · 2022: $216 · 2023: $260 · 2024: $216 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $403.36 | 2021-2025 | |
| Smith+Nephew, INC. | $148.43 | 2025 | Pico 14 |
| Sumitomo Pharma America, INC. | $92.06 | 2023-2024 | Myfembree |
| Organon LLC | $91.52 | 2022-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $85.58 | 2021-2023 | |
| Coopersurgical, INC. | $63.99 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Meditrina | $51.84 | 2021 | |
| Medicem INC. | $50.24 | 2021-2024 | |
| Exact Sciences Corporation | $49.89 | 2025 | The Cologuard Plus Collection Kit |
| Pfizer INC. | $44.80 | 2021-2023 | |
| Therapeuticsmd, INC. | $41.70 | 2022 | |
| Evofem Biosciences, INC. | $39.20 | 2025 | Phexxi, Solosec, Phexx |
| Hologic Sales and Service, LLC | $30.05 | 2024 | Thinprep 2000 Processor, Aptima |
| Distalmotion US | $25.12 | 2025 | Dexter L6 Robot |
| Shield Therapeutics INC | $18.33 | 2023 | Accrufer |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.89 | 2023 | Venaseal |
| Sage Therapeutics, LLC | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosetta Stanford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.